AlphAIAlphAI — Financial news for AI agents
yahoo.comSEP 111 min read$FTK

Flotek raises 2026 revenue guidance to $360 million-$370 million

Flotek Industries (FTK) raised its 2026 revenue guidance to $360M-$370M from $340M-$350M, citing higher international chemistry sales. Adjusted EBITDA guidance increased to $50M-$54M from $47M-$51M. Q2 2026 international chemistry revenue was $10.6M, up over 450% from Q1.

Original reporting
yahoo.com
Published Sep 11, 2026, 1:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 1:15 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Flotek raises 2026 revenue guidance to $360 million-$370 million — source image
Source · yahoo.com
Decision brief

The 30-second read

$FTKBullishHigh
01

Why it matters

The guidance raise is a fresh, material update that could drive short‑term price movement.

02

Market read

Guidance lift provides a clear trading catalyst for FTK and may influence related chemical stocks.

03

What to watch

Potential volatility from foreign exchange risk and stock‑based compensation uncertainties.

Relevance 7/10Novelty 8/10Timing: today

Background

Flotek Industries is a Houston‑based specialty chemicals producer listed on NYSE.

Company-level read

Ticker impact

$FTKBullishHigh confidence
Context

Flotek raised its 2026 revenue guidance to $360M-$370M, up from $340M-$350M, and lifted Adjusted EBITDA guidance.

Expected impact

Potential upside of 5‑10% in the near term.

Evidence & confidence

Guidance lift is a primary disclosure with material dollar scale for a small‑cap, providing a clear catalyst for traders.

Market effects

Sector

Higher international chemistry demand may benefit peer specialty chemicals firms.

Regional

Positive for U.S. small‑cap chemical sector.

Global

Limited to niche chemical market, no broad macro effect.

Counterpoint

What could challenge this read

Guidance may be overly optimistic if international sales falter, risking a pull‑back.

Key entities

  • Company
    Flotek Industries, Inc.

    Specialty chemicals manufacturer.

  • Executive
    Ryan Ezell

    Chief Executive Officer of Flotek.

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 23
$FTKMed

Flotek Secures $120 Million Senior Secured Term Loan to Support Continued Strategic Growth

Flotek Industries (NYSE: FTK) secured a $120 million senior secured term loan, with $75 million available immediately and up to $45 million in delayed-draw commitments. The funds will support capital expenditures, refinance existing debt, and fund working capital. The loan matures in 2031, with no amortization required for the first two years. Elda River Capital Management is the lead lender.

prnewswire.com2 min
SEP 9
$FTKMed

FTK Looks 112.5% Overvalued on GF Value™

Flotek Industries (FTK) raised its 2026 revenue guidance to $360M-$370M, up from $340M-$350M, and adjusted EBITDA to $50M-$54M. The stock surged 6.7% pre-market. FTK's P/S ratio is 3.19x, above historical and industry norms, suggesting overvaluation. The company's GF Score™ is 61/100, indicating moderate financial health.

gurufocus.com2 min
SEP 9
$FTKMed

Flotek raises 2026 revenue guidance to $360-370M, Adjusted EBITDA to $50-54M

Flotek Industries Inc. raised its 2026 revenue guidance to $360-370M from $340-350M and adjusted EBITDA guidance to $50-54M. Q2 revenue was $99.4M, up 70% YoY, with adjusted EBITDA at $16.8M, up 109% YoY. International chemistry sales surged, with Q2 revenue at $10.6M and potential for 2H26 sales to exceed $40M. The company updated its corporate presentation for the Lake Street investor conference.

tradingview.com1 min